| Literature DB >> 35211844 |
Mohammad Kermansaravi1,2, Rohollah Valizadeh3,4, Amirhossein Davarpanah Jazi4,5, Shahab Shahabi Shahmiri4, Jose Antonio Lopez Martinez6, Ali Mousavimaleki4, Foolad Eghbali1,2, Amirhossein Aliakbar4, Hamed Atarodi4, Ebrahim Aghajani7, Panagiotis Lainas8,9.
Abstract
This systematic review and meta-analysis intend to evaluate the efficacy of metabolic/bariatric surgeries (MBS) in patients with type-1 diabetes mellitus. A systematic literature search and meta-analysis were performed in electronic databases up to July 2021. In total, 27 primary studies comprising 648 subjects were included in this systematic review and meta-analysis. Patients had a mean age of 38.0 ± 7.3 years. Preoperative mean BMI was 42.6 ± 4.7 kg/m2 and 29.4 ± 4.7 kg/m2 after surgery, respectively. Following bariatric surgeries in patients with type 1 diabetes mellitus, insulin (unit/day) decreased by a weighted mean difference (WMD) of - 10.59. Also, insulin (unit/kg/day) decreased by a WMD of - 0.2, and HbA1C decreased by a WMD of - 0.71, showing MBS acceptable and durable effects of bariatric surgical procedures.Entities:
Keywords: Bariatric surgery; HbA1C; Insulin; Metabolic surgery; Obesity surgery; Type 1 diabetes mellitus
Mesh：
Substances：
Year: 2022 PMID： 35211844 DOI： 10.1007/s11695-022-05980-7
Source DB: PubMed Journal: Obes Surg ISSN： 0960-8923 Impact factor: 3.479